Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD G 506 A Fluorescence Imaging in Breast Conserving Surgery
NCT04815083Phase 3Terminated
- Sponsor
- SBI ALApharma
- Start
- Apr 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in breast cancer, sponsored by SBI ALApharma. Started Apr 2021; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04815083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815083.